ARS Pharmaceuticals News

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina

Apr 24 18:24 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E

Apr 24 18:19 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina

Apr 22 19:27 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E

Apr 22 19:27 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina

Apr 17 18:45 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E

Apr 17 18:45 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina

Apr 10 17:43 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E

Apr 10 17:38 ET

ARS Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(11.3%),Peter Kolchinsky(11.3%), etc.

Mar 29 16:18 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Mar 27 19:40 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E

Mar 26 18:50 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina

Mar 26 18:50 ET

ARS Pharmaceuticals | 10-K: Annual report

Mar 21 22:22 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E

Mar 21 21:52 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina

Mar 21 21:52 ET

ARS Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 21 17:13 ET

ARS Pharmaceuticals | 8-K: ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 21 16:10 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E

Mar 15 19:57 ET

ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina

Mar 15 19:57 ET

ARS Pharmaceuticals | 8-K: Current report

Mar 7 13:00 ET